Stellant Securities gets BSE trading approval for 1.5 lakh promoter shares

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Stellant Securities received BSE trading approval for 1,50,000 equity shares
  • Shares were allotted to promoters via conversion of warrants on a preferential basis
  • The issue price included a face value of ₹10 and a premium of ₹330 per share
  • Trading commenced on September 16, 2026, following approval dated September 15
powered bylight_fuzz_icon
51186147

*this image is generated using AI for illustrative purposes only.

Stellant Securities (India) Limited received trading approval from the Bombay Stock Exchange for 1,50,000 equity shares allotted to promoters. The shares were issued pursuant to the conversion of warrants on a preferential basis.

The exchange granted the approval effective September 16, 2026. The allotment involves equity shares with a face value of ₹10 each. These securities carry distinctive numbers ranging from 5535996 to 5685995.

Allotment Details

The company disclosed the receipt of the trading approval letter dated September 15, 2026, bearing reference number LOD/PREF/VJ/206/2026-2027. The issuance was made at a premium of ₹330 per share.

Metric Detail
Shares Allotted 1,50,000
Face Value ₹10
Issue Premium ₹330
Distinctive Nos 5535996 to 5685995
Listing Date September 16, 2026

The intimation was issued under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III. Mangala Subhash Rathod, Whole Time Director, signed the disclosure.

Historical Stock Returns for Stellant Securities

1 Day5 Days1 Month6 Months1 Year5 Years
-0.38%-4.73%+1.70%+51.05%+540.92%0.0%

How might the conversion of warrants by promoters signal their confidence in Stellant Securities' future valuation and growth trajectory?

What impact could this preferential allotment have on the existing shareholder structure and potential dilution of equity for minority investors?

Given the high issue premium of ₹330 per share, how does this valuation compare to current market trends for similar brokerage firms in India?

Stellant Securities gets BSE listing approval for 1.5 lakh shares

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • BSE granted in-principle listing approval for 1,50,000 equity shares
  • Shares allotted to promoters via conversion of warrants issued on preferential basis
  • Face value is ₹10 per share with an issue premium of ₹330
  • Trading approval requires filing within seven working days
powered bylight_fuzz_icon
49991469

*this image is generated using AI for illustrative purposes only.

Stellant Securities (India) Limited received in-principle listing approval from the Bombay Stock Exchange for 1,50,000 equity shares allotted to promoters through warrant conversion.

The exchange granted approval on September 2, 2026, for shares with a face value of ₹10 each issued at a premium of ₹330 per share. The distinctive numbers range from 5535996 to 5685995.

Regulatory Compliance

The company must file a trading application within seven working days of listing approval to avoid penalties under SEBI circular no. SEBI/HO/CFD/PoD-2/P/CIR/2023/00094 dated June 21, 2023. Trading approval requires submission of NSE listing approval and confirmation letters from NSDL or CDSL regarding credit to beneficiary accounts.

If shareholding changes exceed two per cent of total paid-up capital, the company must file the pattern in XBRL mode under Regulation 31(1)(c) of SEBI LODR Regulations, 2015. Compliance with Regulation 167 of SEBI ICDR Regulations is also mandatory.

Historical Stock Returns for Stellant Securities

1 Day5 Days1 Month6 Months1 Year5 Years
-0.38%-4.73%+1.70%+51.05%+540.92%0.0%

How might the influx of 1,50,000 promoter shares from warrant conversion impact Stellant Securities' stock price volatility in the short term?

What are the potential implications for minority shareholders if the company fails to meet the seven-day trading application deadline under SEBI regulations?

Could this warrant conversion signal broader strategic shifts in Stellant Securities' capital structure or promoter confidence levels?

More News on Stellant Securities

1 Year Returns:+540.92%